Literature DB >> 20339146

Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction.

Simon Tual-Chalot1, Christelle Guibert, Bernard Muller, Jean-Pierre Savineau, Ramaroson Andriantsitohaina, M Carmen Martinez.   

Abstract

RATIONALE: Pulmonary arterial hypertension (PAH) is a severe disease characterized by an increase of pulmonary vascular resistance, which is accompanied by functional and structural changes in pulmonary arteries. Microparticles (MPs) have been described as biological vector of endothelial dysfunction in other pathologies.
OBJECTIVES: The purpose of this work was to characterize circulating MPs during hypoxic PAH and to study their effects on endothelial function.
METHODS: Male Wistar rats were exposed or not to chronic hypoxia, and normoxic or hypoxic MPs from blood were characterized by flow cytometry. Endothelial cells (ECs) from rat aorta or pulmonary arteries were incubated with MPs, and then expression and phosphorylation of enzymes involved in nitric oxide (NO) and reactive oxygen species productions were analyzed. Hypoxic MPs were injected into rats, and endothelium-dependent relaxation was assessed.
MEASUREMENTS AND MAIN RESULTS: Circulating levels of MPs from hypoxic rats were twofold higher than those present in normoxic rats. In vitro treatment of ECs with hypoxic MPs reduced NO production in aortas and pulmonary arteries by enhancing phosphorylation of endothelial NO synthase at the inhibitory site. Hypoxic MPs increased oxidative stress only in pulmonary ECs via xanthine oxidase and mitochondrial implication. In vivo injection of hypoxic MPs into rat impaired endothelium-dependent relaxation both in aorta and pulmonary arteries.
CONCLUSIONS: These data provide evidence that hypoxic circulating MPs induce endothelial dysfunction in rat aorta and pulmonary arteries by decreasing NO production. Moreover, MPs display tissue specificity with respect to increased oxidative stress, which occurs only in pulmonary ECs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339146     DOI: 10.1164/rccm.200909-1347OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  37 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

2.  Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding.

Authors:  Eleftheria Letsiou; Saad Sammani; Wei Zhang; Tong Zhou; Hector Quijada; Liliana Moreno-Vinasco; Steven M Dudek; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

Review 3.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

Review 4.  Microvesicles: potential markers and mediators of endothelial dysfunction.

Authors:  Ming-Lin Liu; Kevin Jon Williams
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

5.  Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.

Authors:  James R Klinger; Mandy Pereira; Michael Del Tatto; Alexander S Brodsky; Keith Q Wu; Mark S Dooner; Theodore Borgovan; Sicheng Wen; Laura R Goldberg; Jason M Aliotta; Corey E Ventetuolo; Peter J Quesenberry; Olin D Liang
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

6.  Transfer of human hepatocyte growth factor reduces inflammation and prevents pulmonary arterial remodeling in monocrotaline-induced.

Authors:  Jianying Chen; Hongzhe Zhang; Rujun Zhang; Zhenjun Liu; Junxian Wang; Mengyuan Xiao; Mingchuan Ba; Feng Yao; Jinghu Liu; Shi'an Huang; Jixin Zhong
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 7.  Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.

Authors:  Yuansheng Gao; Tianji Chen; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

8.  Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.

Authors:  Jason M Aliotta; Mandy Pereira; Ashley Amaral; Arina Sorokina; Zenas Igbinoba; Alexander Hasslinger; Rabih El-Bizri; Sharon I Rounds; Peter J Quesenberry; James R Klinger
Journal:  Cardiovasc Res       Date:  2013-07-18       Impact factor: 10.787

9.  Endothelial Extracellular Vesicles in Pulmonary Function and Disease.

Authors:  Eleftheria Letsiou; Natalie Bauer
Journal:  Curr Top Membr       Date:  2018-10-08       Impact factor: 3.049

10.  Increased endothelial microparticles and oxidative stress at extreme altitude.

Authors:  Jacqueline Pichler Hefti; Alexander Leichtle; Monika Stutz; Urs Hefti; Thomas Geiser; Andreas R Huber; Tobias M Merz
Journal:  Eur J Appl Physiol       Date:  2016-01-28       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.